Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10,705 GBX | -0.34% | +2.65% | +0.98% |
01:19pm | ASTRAZENECA : Deutsche Bank reiterates its Sell rating | ZD |
Mar. 27 | AstraZeneca CEO Sees No Impact from Biosecure Act | MT |
Chart calendar AstraZeneca PLC
Upcoming events on AstraZeneca PLC
Past events on AstraZeneca PLC
2024-03-26 | BNP Exane Healthcare Conference |
2024-03-22 10:00 am | Business Update Call |
2024-03-18 | Investor Meeting - Berenberg Majority Investors |
2024-03-18 | Investor Meeting - Capital Research Global Euro Focus |
2024-03-13 | Investor Meeting - Bank of America Bus Tour |
2024-03-11 | Roadshow - JP Morgan |
2024-03-11 | Barclays Global Healthcare Conference |
2024-03-10 | Roadshow - JP Morgan |
2024-03-10 | Leerink Partners Global Biopharma Conference |
2024-03-06 | Daiwa Investment Conference |
2024-03-06 | Roadshow - Rothschild |
2024-03-05 | Roadshow - BNPP Exane |
2024-03-04 | Roadshow - BNPP Exane |
2024-03-04 | Roadshow - Day - 2 |
2024-03-03 | TD Cowen Health Care Conference |
2024-03-03 | Roadshow - Day - 1 |
2024-03-02 | Roadshow |
2024-02-26 | UBS European Healthcare Conference |
2024-02-21 | Final dividend |
2024-02-21 | Citi Oncology Leadership Summit |
Past dividends on AstraZeneca PLC
2024-02-21 | Final Payment 1.56 GBP |
2023-08-09 | Interim Payment 0.718 GBP |
2023-02-22 | Final Payment 1.628 GBP |
2022-08-10 | Interim Payment 0.764 GBP |
2022-02-23 | Final Payment 1.453 GBP |
2021-08-11 | Interim Payment 0.648 GBP |
2021-02-24 | Final Payment 1.374 GBP |
2020-08-12 | Interim Payment 0.696 GBP |
2020-02-26 | Final Payment 1.464 GBP |
2019-08-07 | Interim Payment 0.719 GBP |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 24 384 24 440 -0.23% | 26 617 26 378 0.91% | 37 417 36 239 3.25% | 44 351 44 465 -0.26% | 45 811 45 716 0.21% | 51 007 |
EBITDA Million USD | Released Forecast Spread | 6 686 6 882 -2.84% | 8 311 8 087 2.76% | 7 586 10 816 -29.87% | 9 237 13 681 -32.49% | 13 580 15 477 -12.26% | 17 797 |
EBIT Million USD | Released Forecast Spread | 6 436 6 631 -2.95% | 7 340 7 417 -1.04% | 9 928 10 003 -0.75% | 13 350 13 702 -2.57% | 14 534 15 036 -3.34% | 16 755 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 548 2 130 -27.34% | 3 916 4 387 -10.74% | -265 1 510 -117.55% | 2 501 3 511 -28.78% | 6 899 9 269 -25.57% | 10 465 |
Net income Million USD | Released Forecast Spread | 1 335 1 895 -29.55% | 3 196 2 930 9.09% | 112 2 055 -94.55% | 3 288 4 262 -22.86% | 5 961 6 597 -9.64% | 8 974 |
EPS USD | Released Forecast Spread | 1,03 1,41 -26.77% | 2,44 2,50 -2.26% | 0,08 1,99 -95.98% | 2,11 2,81 -24.96% | 3,81 4,34 -12.2% | 5,69 |
Announcement Date | 14/02/20 | 11/02/21 | 10/02/22 | 09/02/23 | 08/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 12 011 11 079 8.41% | 11 390 10 967 3.86% | 10 771 10 577 1.83% | 10 982 10 848 1.23% | 11 207 11 287 -0.71% | 10 879 10 559 3.03% | 11 416 11 018 3.62% | 11 492 11 529 -0.32% | 12 024 12 007 0.14% | 12 047 | 12 486 | 12 871 | 13 531 | 12 830 |
EBITDA Million USD | Released Forecast Spread | 1 900 4 512 -57.89% | 2 187 3 894 -43.83% | 1 896 5 337 -64.47% | 2 579 2 556 0.88% | 2 574 2 966 -13.22% | 3 732 4 074 -8.39% | ||||||||
EBIT Million USD | Released Forecast Spread | 3 318 3 291 0.82% | 3 961 3 486 13.62% | 3 365 3 291 2.25% | 3 413 3 189 7.03% | 2 610 2 916 -10.5% | 3 946 3 517 12.21% | 4 291 4 005 7.13% | 3 545 3 537 0.24% | 2 752 3 206 -14.15% | 4 274 | 4 067 | 4 319 | 4 020 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -636 1 321 -148.13% | 553 972 -43.08% | 247 580 -57.38% | 922 1 007 -8.4% | 778 806 -3.47% | 2 262 1 834 23.34% | 2 088 2 410 -13.36% | 1 652 2 510 -34.17% | 897 1 671 -46.32% | 2 563 | 2 638 | 3 028 | 2 557 | |
Net income Million USD | Released Forecast Spread | -347 1 010 -134.35% | 386 1 086 -64.45% | 360 946 -61.96% | 1 640 895 83.16% | 901 2 096 -57.02% | 1 803 1 594 13.14% | 1 818 2 123 -14.37% | 1 378 1 705 -19.16% | 959 2 313 -58.53% | 2 421 | 2 188 | 2 369 | 2 219 | |
EPS USD | Released Forecast Spread | -0,22 0,62 -135.33% | 0,25 0,70 -64.25% | 0,23 0,78 -70.61% | 1,05 0,58 82.48% | 0,58 1,35 -57.11% | 1,16 1,08 7.44% | 1,17 1,36 -14.03% | 0,89 1,09 -18.64% | 0,62 1,49 -58.3% | 1,55 | 1,40 | 1,52 | 1,42 | |
Announcement Date | 10/02/22 | 29/04/22 | 29/07/22 | 10/11/22 | 09/02/23 | 27/04/23 | 28/07/23 | 09/11/23 | 08/02/24 | - | - | - | - | - |
Past sector events for AstraZeneca PLC
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock AstraZeneca PLC - London S.E.
- Calendar AstraZeneca PLC